Using odor blockers to help people quit smoking
Human Perception of Odors and Odor Blockers
This study tests if using odor blockers can help people quit smoking by reducing their urge to smoke when they smell cigarette smoke.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | University of Kentucky Academic / other |
| Locations | 1 site (Lexington, Kentucky) |
| Trial ID | NCT06191419 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of odor blockers in reducing the perception of cigarette smoke odors to aid smoking cessation. Participants will inhale various odor samples, including cigarette smoke and odor blockers, while reporting their experiences regarding odor pleasantness and their desire to smoke. The study aims to determine if blocking the smell of cigarette smoke can decrease the urge to smoke. Each participant will undergo multiple sessions with randomized odor presentations to assess their responses accurately.
Who should consider this trial
Good fit: Ideal candidates for this study are current smokers who are willing to participate in odor perception assessments.
Not a fit: Patients who are non-smokers or have self-reported difficulties in smelling or tasting will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a novel method for smokers to reduce cravings and aid in quitting smoking.
How similar studies have performed: While the use of odor blockers in smoking cessation is a novel approach, similar studies exploring sensory perception and smoking behaviors have shown promise.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Smoker Exclusion Criteria: * Non Smoker * Self reported inability to smell or taste
Where this trial is running
Lexington, Kentucky
- University of Kentucky — Lexington, Kentucky, United States (Recruiting)
Study contacts
- Principal investigator: Timothy McClintock, PhD — University of Kentucky
- Study coordinator: Timothy McClintock, PhD
- Email: mcclint@uky.edu
- Phone: 8593231083
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.